StockData
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31

DiaMedica Therapeutics Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$7.87+0.30 (+3.96%)

Close on Oct 19, 2026

Market cap
$424.15M
P/E (TTM)
–
Dividend yield
–

SEC filings

40 of DiaMedica Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QJun 30, 2026Aug 10, 2026SEC EDGAR
Current report8-KAug 10, 2026Aug 10, 2026SEC EDGAR
Current report8-KMay 20, 2026May 21, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 6, 2026SEC EDGAR
Current report8-KMay 6, 2026May 6, 2026SEC EDGAR
Proxy statementDEF 14AMay 20, 2026Apr 1, 2026SEC EDGAR
Current report8-KMar 30, 2026Mar 31, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 30, 2026SEC EDGAR
Current report8-KJan 5, 2026Jan 5, 2026SEC EDGAR
Current report8-KDec 18, 2025Dec 18, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 12, 2025SEC EDGAR
Current report8-KNov 12, 2025Nov 12, 2025SEC EDGAR
Current report8-KAug 12, 2025Aug 12, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 12, 2025SEC EDGAR
Current report8-KAug 12, 2025Aug 12, 2025SEC EDGAR
Current report8-KAug 4, 2025Aug 6, 2025SEC EDGAR
Current report8-KJul 21, 2025Jul 21, 2025SEC EDGAR
Current report8-KJul 17, 2025Jul 17, 2025SEC EDGAR
Current report8-KMay 15, 2025May 15, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 13, 2025SEC EDGAR
Current report8-KMay 13, 2025May 13, 2025SEC EDGAR
Proxy statementDEF 14AMay 15, 2025Mar 28, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 17, 2025SEC EDGAR
Current report8-KMar 17, 2025Mar 17, 2025SEC EDGAR
Current report8-KFeb 28, 2025Mar 6, 2025SEC EDGAR
Current report8-KFeb 20, 2025Feb 24, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 13, 2024SEC EDGAR
Current report8-KNov 13, 2024Nov 13, 2024SEC EDGAR
Current report8-KAug 7, 2024Aug 7, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 7, 2024SEC EDGAR
Current report8-KJun 25, 2024Jun 26, 2024SEC EDGAR
Current report8-KJun 26, 2024Jun 26, 2024SEC EDGAR
Current report8-KMay 22, 2024May 23, 2024SEC EDGAR
Quarterly report10-QMar 31, 2024May 8, 2024SEC EDGAR
Current report8-KMay 8, 2024May 8, 2024SEC EDGAR
Current report8-KApr 5, 2024Apr 10, 2024SEC EDGAR
Proxy statementDEF 14AMay 22, 2024Apr 4, 2024SEC EDGAR
Annual report10-KDec 31, 2023Mar 19, 2024SEC EDGAR
Current report8-KMar 19, 2024Mar 19, 2024SEC EDGAR
Quarterly report10-QSep 30, 2023Nov 13, 2023SEC EDGAR